FDA Drug Application (203684) for LUMASON by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number203684
Product Number001
FormFOR SUSPENSION;INTRAVENOUS
Dosage60.7MG/25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLUMASON
Active IngredientSULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES



Back to FDA Applications sponsored by BRACCO

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.